EPIDEMIOLOGY OF GASTRIC CANCER IN KAZAKHSTAN IN 2005-2014

  • Authors: Zhandossov OK1, Kausova GK1, Emberdiyev AZ1, Lurye AZ2, Ivanov SV3, Dubovichenko D4, Grjibovski AM4,5,6,7
  • Affiliations:
    1. Высшая школа общественного здравоохранения Минздрава Республики Казахстан
    2. Клиника инновационной терапии «Древо жизни»
    3. Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова
    4. Северный государственный медицинский университет
    5. Национальный институт общественного здравоохранения
    6. Северо-Восточный федеральный университет
    7. Международный казахско-турецкий университет
  • Issue: Vol 24, No 6 (2017)
  • Pages: 50-57
  • Section: Articles
  • URL: https://journals.rcsi.science/1728-0869/article/view/16797
  • DOI: https://doi.org/10.33396/1728-0869-2017-6-50-57
  • ID: 16797

Cite item

Full Text

Abstract

An analysis of the gastric cancer incidence, mortality, five-year survival rate and the frequency of early revealing in the Republic of Kazakhstan for the period 2005-2014 was performed. As a result of the study, a statistically significant trend in declining incidence (from 18.9 to 16.4 per 100 000 population) and mortality from (from 15.0 to 11.8 per 100 000 population) was revealed. The frequency of early detection of gastric cancer (I-II stages) increased from 16.8 % to 34.2 %, but the five-year survival rate began to increase only in 2012. The incidence of gastric cancer decreased in 5 regions of Kazakhstan, mortality decreased in 9 regions, the increase in the frequency of early detection was observed in 8 regions of 16.

About the authors

O K Zhandossov

Высшая школа общественного здравоохранения Минздрава Республики Казахстан

Kazakh National School of Public Health Almaty, Kazakhstan

G K Kausova

Высшая школа общественного здравоохранения Минздрава Республики Казахстан

Kazakh National School of Public Health Almaty, Kazakhstan

A Z Emberdiyev

Высшая школа общественного здравоохранения Минздрава Республики Казахстан

Kazakh National School of Public Health Almaty, Kazakhstan

A Z Lurye

Клиника инновационной терапии «Древо жизни»

Innovation therapy clinic "Drevo Zhizni" Almaty, Kazakhstan

S V Ivanov

Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова

First St. Petersburg State Medical University n. a. I.P. Pavlov Saint Petersburg, Russia

D Dubovichenko

Северный государственный медицинский университет

Northern State Medical University Arkhangelsk, Russia

A M Grjibovski

Северный государственный медицинский университет; Национальный институт общественного здравоохранения; Северо-Восточный федеральный университет; Международный казахско-турецкий университет

Email: Andrej.Grjibovski@gmail.com
Northern State Medical University, 5Norwegian Institute of Public Health, 6North-Eastern Federal University, 7International Kazakh-Turkish University INFA, Nasjonalt folkehelseinstitutt, Postboks 4404 Nydalen, 0403 Oslo, Norway. Arkhangelsk, Russia; Yakutsk, Russia; Turkestan, Kazakhstan

References

  1. Гржибовский А. М. Однофакторный линейный регрессионный анализ // Экология человека. 2008. № 10. С. 55-64
  2. Каприн А. Д., Старинский В. В., Петрова Г. В. Злокачественные новообразования в России в 2015 году (заболеваемость и смертность). М.: МНИОИ им. П. А. Герцена филиал ФГБУ «НМИРЦ» Минздрава России, 2017. 250 с.
  3. Холматова К. К., Гржибовский А. М. Панельные исследования и исследования тренда в медицине и общественном здравоохранении // Экология человека. 2016. № 10. С. 57-64.
  4. Холматова К. К., Харькова О. А., Гржибовский А. М. Классификация научных исследований в здравоохранении // Экология человека. 2016. № 1. С. 57-64.
  5. Черенков В. Г. Клиническая онкология: учеб. пособие для системы последипломного образования врачей. М.: МК, 2010. 434 с.
  6. Amiri M., Janssen F., Kunst A. E. The decline in stomach cancer mortality: exploration of future trends in seven European countries // European Journal of Epidemiology. 2011. Vol. 26 (1). P. 23-28.
  7. Camargo M. C., Kim W. H., Chiaravalli A. M. et al. Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis // Gut. 2014. Vol. 63 (2). P. 236-243.
  8. Crew K. D., Neugut A. I. Epidemiology of gastric cancer // World Journal of Gastroenterology. 2006. Vol. 12 (3). P. 354-362.
  9. Den Hoed C. M., Kuipers E. J. Gastric cancer: how can we reduce the incidence of this disease? // Current Gastroenterology Reports. 2016. Vol. 18. P. 34.
  10. Ferlay J., Shin H. R., Bray F., Forman D., Mathers C., Parkin D. M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 // International Journal of Cancer. 2010. Vol. 127 (12). P. 2893-2917.
  11. Fock K. M., Talley N., Moayyedi P. et al. Asia-Pacific consensus guidelines on gastric cancer prevention // Journal of Gastroenterology and Hepatology. 2008. Vol. 23 (3). P. 351-365.
  12. Forman D., Burley V. J. Gastric cancer: global pattern of the disease and an overview of environmental risk factors // Best Practice and Research. Clinical Gastroenterology. 2006. Vol. 20 (4). P. 633-649.
  13. Glade M. J. Food, nutrition, and the prevention of cancer: a global perspective. American Institute for Cancer Research/World Cancer Research Fund, American Institute for Cancer Research, 1997 // Nutrition. 1999. Vol. 15 (6). P. 523-536.
  14. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. URL: http://globocan.iarc.fr/Default.aspx (дата обращения 24.02.2017).
  15. Hamashima C., Ogoshi K., Narisawa R., Kishi T., Kato T., Fujita K., Sano M., Tsukioka S. Impact of endoscopic screening on mortality reduction from gastric cancer // World Journal of Gastroenterology. 2015. Vol. 21 (8). P. 2460-2466.
  16. Huang Y. K., Yu J. C., Kang W. M, Ma Z. Q, Ye X, Tian S. B., Yan C. Significance of serum pepsinogens as a biomarker for gastric cancer and atrophic gastritis screening: a systematic review and meta-analysis // PLoS One. 2015. Vol. 10 (11). P. 654-660.
  17. International Agency for Research on Cancer Unit of Descriptive Epidemiology: WHO cancer mortality databank. Cancer Mondial, 2001. URL: http://www-dep.iarc.fr/ataava/ globocan/who.htm (дата обращения 02.03.2017).
  18. International Agency for Research on Cancer Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, Liver Flukes, and Helicobacter pylori. Lyon: International Agency for Research on Cancer. 1994. P. 177-240.
  19. Isobe Y., Nashimoto A., Akazawa K, Oda I., Hayashi K., Miyashiro I., Katai H., Tsujitani S., Kodera Y., Seto Y., Kaminishi M. Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry // Gastric Cancer. 2011. Vol. 14 (4). P. 301-316.
  20. Jemal A., Center M. M., DeSantis C., Ward E. M. Global patterns of cancer incidence and mortality rates and trends // Cancer Epidemiology, Biomarkers and Prevention. 2010. Vol. 19 (8). P. 1893-1907.
  21. Karimi P., Islami F., Anandasabapathy S., Freedman N. D., Kamangar F. Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention // Cancer Epidemiology, Biomarkers and Prevention. 2014. Vol. 23 (5). P. 700-713.
  22. Leung W. K., Wu M. S., Kakugawa Y. et al. Screening for gastric cancer in Asia: current evidence and practice // The Lancet. Oncology. 2008. Vol. 9 (3). P. 279-287.
  23. Ohata H., Kitauchi S., Yoshimura N. et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer // International Journal of Cancer. 2004. Vol. 109 (1). P. 138-143.
  24. Siegel R., Ma J., Zou Z., Jemal A. Cancer statistics, 2014 // CA: A Cancer Journal for Clinicians. 2014. Vol. 64 (1). P. 9-29.
  25. Stewart B. W., Kleihues P. World Cancer Report. Lyon: IARC Press, 2003.
  26. Tredaniel J., Boffetta P., Buiatti E., Saracci R., Hirsch A. Tobacco smoking and gastric cancer: review and meta-analysis // International Journal of Cancer. 1997. Vol. 72 (4). P. 565-573.
  27. Yanaoka K., Oka M., Yoshimura N. et al. Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels // International Journal of Cancer. 2008. Vol. 123 (4). P. 917-926.
  28. Yoshida T., Kato J., Inoue I. et al. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer // International Journal of Cancer. 2014. Vol. 134 (6). P. 1445-1457.

Copyright (c) 2017 Human Ecology


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies